ReviewClinical liver disease2017
Congestive hepatopathy: Differentiating congestion from fibrosis.
Review in Clinical liver disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- The Liver as a Biomarker Organ in Heart Failure: Molecular Mechanisms, Hepatic Scores and Systemic Risk Stratification.International journal of molecular sciences · 2026Review
- Concomitant pericardiectomy and coronary artery bypass grafting associated with marked reduction in liver stiffness in a patient with constrictive pericarditis: a case report.Journal of cardiothoracic surgery · 2026Article
- Long-Term Care in Fontan Circulation: Surveillance and Management of Fontan-Associated Liver Disease and Protein-Losing Enteropathy.Current cardiology reports · 2026Review
- New Treatment Options for MASLD Patients with Type 2 Diabetes.Life (Basel, Switzerland) · 2026Review
- Assessing Venous Congestion in Acute and Chronic Heart Failure: A Review of Splanchnic, Cardiac and Pulmonary Ultrasound: Part 1: Conventional B-Mode, Colordoppler, and Vexus Protocol.Journal of clinical medicine · 2025Review
- Clinical utility of the Fibrosis-4 index for predicting mortality in patients with heart failure with or without metabolic dysfunction-associated steatotic liver disease: a prospective cohort study.The Lancet regional health. Europe · 2025Article
- Liver dysfunction as a rare presentation of ICD lead-induced tricuspid regurgitation: a case report.European heart journal. Case reports · 2024Article
- Pediatric Combined Heart-liver Transplantation: A Single-center Long-term Experience.Transplantation direct · 2024Article
- Congestive Hepatopathy Diagnosed by Venous Excess Ultrasound Score.ACG case reports journal · 2024Article
- Use of liver stiffness measurements in acute decompensated heart failure: new applications of a non-invasive technique.ESC heart failure · 2022Review
- Striking Elevations in Aminotransferases in a Case of Congestive Hepatopathy Without Concurrent Hypotension.Cureus · 2022Article
- Surgical Correction of Carcinoid Heart Disease Improves Liver Function and 5-Hydroxyindoleacetic Acid Levels.Frontiers in surgery · 2022Article
- Congestive Hepatopathy.International journal of molecular sciences · 2020Review
- Congestive hepatopathy: the role of the radiologist in the diagnosis.Diagnostic and interventional radiology (Ankara, Turkey) · 2020Article
- MicroRNA-29b/c-3p Indicate Advanced Liver Fibrosis/Cirrhosis in Univentricular Heart Patients With and Without Fontan Palliation.Frontiers in cardiovascular medicine · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.